Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Marie Skłodowska-Curie Action · Running

EstroPatch Continuous Estrogen Monitoring Patch

Coordinator
Katholieke Universiteit Leuven, Belgium
Runs
1 June 2027 to 31 May 2030
Status
Running
EU funding
€321k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101274126

What the project is doing

In the project's own words, from its summary on CORDIS.

Estrogen monitoring is crucial across genders for tracking conditions like infertility (1 in 6 globally), breast/uterine cancers, postpartum depression, and schizophrenia. Endocrine cancers are rising in the EU (>100,000 neuroendocrine tumor cases, 60% at late stage), with endocrine-disrupting chemicals contributing significantly. Current estrogen monitoring methods are effective but invasive, hospital-based, and dependent on bulky instrumentation, making regular monitoring challenging.

Therefore, there is a vital need to develop a highly sensitive, user-friendly wearable biosensing platform for continuous, on-site estrogen monitoring to ensure effective medical decision-making. Electrochemical biosensors offer high sensitivity and rapid response, making them ideal for wearable estrogen monitoring. Microneedle-based systems enable reliable, minimally invasive hormone detection through direct access to dermal interstitial fluid.

This proposal aims to develop, for the first time, EstroPatch—a wearable patch for real-time, continuous monitoring of estrone, estradiol, and estriol levels in dermal interstitial fluid by integrating microneedles, electrochemical sensing, microfluidics, and wireless communication. This will address the current lack of microneedle-integrated systems for estrogen detection. In this project, I propose a multiplexed estrogen monitoring system spanning 0.1–5000 pg/mL using electrochemical sensing with optimized detection and quantitation limits.

By integrating microneedles, I aim to develop EstroPatch as a pain-free, easy-to-use, and cost-effective solution for applications such as pregnancy monitoring, menstrual cycle tracking, and cancer treatment.

Topics

Who is involved

OrganisationCityCountryRole
Katholieke Universiteit LeuvenLeuvenBelgiumCoordinator
Royal Institution for the Advancement of Learning Mcgill UniversityMontrealCanadaAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI